- The
hemp-CBD industry is estimated to reach $22 billion by 2020
- While
still focusing on providing financial information and services,
ChineseInvestors.com also aims to be a recognizable leader in the
hemp-based CBD oil industry
- The
company is considering a Nasdaq IPO for subsidiary CBD Biotech Co. Ltd. by
late FY2019 or the following year
ChineseInvestors.com Inc. (OTCQB: CIIX), a leading financial
information website for Chinese-speaking investors in the United States and
Canada, is looking to gain momentum in its hemp-based CBD product and service
division through a variety of avenues.
Aside from retail, online and direct sales of hemp-based
products, the company has also historically offered customers a wide variety of
products and services, including real-time market commentary, as well as
analysis and education-related services in Chinese language character sets.
ChineseInvestors.com has cultivated a highly diversified
revenue stream and has made inroads into the growing cannabis and CBD oil
industry in several ways. The company developed a Chinese language application
for the cannabis industry, and, in 2016, it launched a new website which could
distribute industrial hemp-based CBD products.
ChineseInvestors.com aims to be a recognizable leader in the
hemp-based CBD oil industry. In China, hemp-based CBD is legal as an additive
to cosmetics, and this allows for a potential market of nearly two billion
people desirous of quality CBD-infused products. As a standalone market
distinct from cannabis itself, the hemp-CBD market is estimated to reach $22
billion by 2022, according to a study by the Brightfield Group (http://ibn.fm/CDOlD). As more of
mainland China’s population sees the benefits of CBD oil products, the
blossoming industry is poised for strong growth in that region.
Another aspect of ChineseInvestors.com’s growth strategy can
be seen in the company’s acquisition of foreign enterprise CBD Biotech Co. Ltd.
Referring to its pursuit of a national securities exchange listing for CBD
Biotech, ChineseInvestors.com CEO and founder Warren Wang said in a news
release (http://ibn.fm/EUHEZ),
“This is a part of a series of actions we have put into place to execute…our
strategic plan to spin-out CBD Biotech.”
Wang continued, stating his belief that “listing on a
national exchange speaks to the quality of CBD Biotech, will provide us with
market visibility and access to capital, and further support our growth
strategy.” He mentioned that the company hopes for a Nasdaq IPO of CBD Biotech late
in FY2019 or early the following year (http://ibn.fm/eSl9z).
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
